Search All UT System Experts

Addition of AEG35156 XIAP antisense oligonucleotide in reinduction chemotherapy does not improve remission rates in patients with primary refractory acute myeloid leukemia in a randomized phase II study

Aaron D. Schimmer, Wolfgang Herr, Mathias Hänel, Gautham Borthakur, Arthur Frankel, Heinz August Horst, Sonja Martin, Jeannine Kassis, Pierre Desjardins, Karen Seiter, Walter Fiedler, Richard Noppeney, Aristoteles Giagounidis, Christine Jacob, Jacques Jolivet, Martin S. Tallman, Steffen Koschmieder

Research output: Contribution to journal › Article › peer-review

47 Scopus citations

Fingerprint

Dive into the research topics of 'Addition of AEG35156 XIAP antisense oligonucleotide in reinduction chemotherapy does not improve remission rates in patients with primary refractory acute myeloid leukemia in a randomized phase II study'. Together they form a unique fingerprint.

Medicine & Life Sciences